Your browser doesn't support javascript.
loading
PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer.
Torres-Ayuso, Pedro; Katerji, Meghri; Mehlich, Dawid; Lookingbill, Sophia A; Sabbasani, Venkata R; Liou, Hope; Casillas, Andrea L; Chauhan, Shailender S; Serwa, Remigiusz; Rubin, Maxine R; Marusiak, Anna A; Swenson, Rolf E; Warfel, Noel A; Brognard, John.
Affiliation
  • Torres-Ayuso P; Laboratory of Cell and Developmental Signaling, National Cancer Institute, NIH, Frederick, MD 21702, USA; Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
  • Katerji M; Laboratory of Cell and Developmental Signaling, National Cancer Institute, NIH, Frederick, MD 21702, USA.
  • Mehlich D; Laboratory of Cell and Developmental Signaling, National Cancer Institute, NIH, Frederick, MD 21702, USA; Laboratory of Molecular OncoSignalling, IMol Polish Academy of Sciences, 00-783 Warsaw, Poland; Doctoral School of the Medical University of Warsaw, 02-091 Warsaw, Poland.
  • Lookingbill SA; Laboratory of Cell and Developmental Signaling, National Cancer Institute, NIH, Frederick, MD 21702, USA.
  • Sabbasani VR; Chemistry and Synthesis Center, National Heart Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.
  • Liou H; University of Arizona Cancer Center, Tucson, AZ 85724, USA; Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ 85724, USA.
  • Casillas AL; University of Arizona Cancer Center, Tucson, AZ 85724, USA.
  • Chauhan SS; University of Arizona Cancer Center, Tucson, AZ 85724, USA; Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ 85724, USA.
  • Serwa R; ReMedy International Research Agenda Unit, IMol Polish Academy of Sciences, 00-783 Warsaw, Poland.
  • Rubin MR; Laboratory of Cell and Developmental Signaling, National Cancer Institute, NIH, Frederick, MD 21702, USA.
  • Marusiak AA; Laboratory of Molecular OncoSignalling, IMol Polish Academy of Sciences, 00-783 Warsaw, Poland.
  • Swenson RE; Chemistry and Synthesis Center, National Heart Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.
  • Warfel NA; University of Arizona Cancer Center, Tucson, AZ 85724, USA; Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ 85724, USA. Electronic address: warfelna@arizona.edu.
  • Brognard J; Laboratory of Cell and Developmental Signaling, National Cancer Institute, NIH, Frederick, MD 21702, USA. Electronic address: john.brognard@nih.gov.
Cell Chem Biol ; 31(2): 326-337.e11, 2024 Feb 15.
Article in En | MEDLINE | ID: mdl-38016478
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Drug Resistance, Neoplasm Limits: Humans / Male Language: En Journal: Cell Chem Biol Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Drug Resistance, Neoplasm Limits: Humans / Male Language: En Journal: Cell Chem Biol Year: 2024 Document type: Article